Evaluation of CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Saliva of Menstrual Migraine Patients Before and After Treatment With Treximet™
Phase of Trial: Phase IV
Latest Information Update: 04 Jun 2014
At a glance
- Drugs Naproxen sodium/sumatriptan (Primary)
- Indications Menstrual migraine
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 06 May 2011 Actual initiation date (May 2011) added as reported by ClinicalTrials.gov.
- 06 May 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.